WebApr 1, 2024 · Abiraterone is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer. Along with its needed effects, abiraterone (the active ingredient contained in Yonsa) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor immediatelyif any of the following side effects occur while taking … See more Some side effects of abiraterone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Some side effects may not be … See more
Yonsa Side Effects: Common, Severe, Long Term
WebThe most common side effects include hot flashes/sweats, fatigue, weakness, muscle pain, dizziness, clamminess, testicular shrinkage, decreased erections and enlargement of breasts. Other side effects, including thinning of bones thatmay lead to fracture, and rare but serious problems with the pituitary gland in the brain, have been reported with ELIGARD. WebDec 22, 2024 · Yonsa is used in combination with methylprednisolone because methylprednisolone helps to prevent some of the side effects caused by Yonsa. CYP17 … can hamsters eat scrambled eggs
Can You Mix the COVID Vaccine and Medications? - AARP
WebOct 31, 2014 · This review evaluates the basis for the effects of prednisone on mineralocorticoid-related adverse events that arise because of CYP17A1 inhibition with abiraterone. Coadministration with the recommended dose of glucocorticoid compensates for abiraterone-induced reductions in serum cortisol and blocks the compensatory … WebYONSA MPRED (tablet) is indicated for the treatment of patients with: newly diagnosed high-risk metastatic hormone sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT), or. patients with metastatic advanced prostate cancer (castration resistant prostate cancer, mCRPC) who are asymptomatic or mildly ... WebOlanib Capsules also use to treat a certain type of prostate cancer that has spread to other parts of the body, no longer responds to medical or surgical treatments to lower testosterone levels, and has progressed after treatment with enzalutamide (Xtandi) or abiraterone (Yonsa, Zytiga). fitear monet17